Generic Medicine Pharma
Abeclib® (Abemaciclib) 150mg
Abeclib® (Abemaciclib) 150mg
Abeclib® 150mg contains Abemaciclib, a CDK4/6 inhibitor used to treat HR-positive, HER2-negative advanced or metastatic breast cancer. It works by blocking proteins that promote cancer cell division and growth.
| Field | Details |
|---|---|
| Original Brand | Verzenio |
| Generic Brand | Abeclib® |
| Generic Name | Abemaciclib 150mg |
| Pack Size | 30 Tablets |
| Use / Indications | HR-Positive, HER2-Negative Breast Cancer |
| Manufacturer | — |
| Status | Prescription Only Medicine |
Introduction to Verzenio (Abemaciclib) 150mg
Verzenio (Abemaciclib) 150mg is a targeted prescription medicine used in the treatment of certain types of breast cancer, particularly hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. It belongs to a class of drugs known as CDK4/6 inhibitors, which help control cancer cell growth.
Abeclib® (Abemaciclib) 150mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Oral Anticancer Drugs. It contains Abemaciclib, which works by blocking proteins involved in cancer cell division.
In some markets, Abeclib® 150mg is available as a generic version of Abemaciclib, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.
What Is Verzenio (Abemaciclib) 150mg?
Verzenio is the original brand name for Abemaciclib, an oral targeted therapy used to treat certain types of breast cancer.
Abemaciclib belongs to a group of medicines known as CDK4/6 inhibitors. These drugs block cyclin-dependent kinases (CDK4 and CDK6), which are essential for cancer cell division.
Generic versions such as Abeclib® 150mg contain the same active ingredient and may be used depending on physician recommendation and availability.
Drug Class and Mechanism of Action
Abemaciclib is classified as a CDK4/6 inhibitor with strong antineoplastic properties.
How Abemaciclib Works
It works in several ways:
- Inhibits CDK4 and CDK6 enzymes
- Stops cancer cells from progressing through the cell cycle
- Slows tumor growth and spread
Through these mechanisms, Abemaciclib helps control cancer progression.
How Verzenio Works in the Body
Abemaciclib targets specific proteins that regulate the cell cycle, preventing cancer cells from multiplying.
Key Actions of Abemaciclib
- Blocks cell cycle progression
- Reduces tumor growth
- Promotes cancer cell death
Generic versions like Abeclib® provide similar therapeutic effects when used correctly.
Medical Uses of Verzenio (Abemaciclib) 150mg
Abeclib® 150mg is widely used in breast cancer treatment.
Abemaciclib for Breast Cancer
It is used in HR-positive, HER2-negative advanced or metastatic breast cancer.
Potential Benefits
- Slows disease progression
- Improves survival outcomes
- Works effectively in combination with hormonal therapies
Who Can Take Abeclib® (Abemaciclib) 150mg?
This medicine must be used under specialist supervision.
Eligibility Criteria
Patients may be prescribed Abemaciclib if they:
- Have HR-positive, HER2-negative breast cancer
- Require targeted therapy
- Are evaluated by an oncologist
Who Should Avoid Verzenio (Abemaciclib) 150mg
Abemaciclib should NOT be used by:
- Pregnant or breastfeeding women
- Patients with severe liver impairment without monitoring
- Individuals with hypersensitivity to Abemaciclib
Verzenio (Abemaciclib) 150mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Abeclib® 150mg twice daily
- Taken with or without food
- Swallowed whole with water
Dosage Adjustments
Doctors may adjust the dose depending on:
- Side effects
- Liver function
- Treatment response
Side Effects of Abemaciclib 150mg
Like all cancer medicines, Abemaciclib may cause side effects.
Common Side Effects
- Diarrhea
- Fatigue
- Nausea
- Decreased appetite
Serious Side Effects
- Severe diarrhea and dehydration
- Liver toxicity
- Blood clots
- Low white blood cell count (neutropenia)
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 30°C in a dry place, protected from moisture and light. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Abeclib® (Abemaciclib) 150mg used for?
It is used to treat HR-positive, HER2-negative advanced or metastatic breast cancer.
2. Is Abemaciclib chemotherapy?
No. It is a targeted therapy (CDK4/6 inhibitor), not traditional chemotherapy.
3. Can Abemaciclib be taken alone?
Yes, but it is often used in combination with hormonal therapies.
4. How long is treatment continued?
Treatment continues as long as it is effective and tolerated.
5. Is Abeclib® the same as Verzenio?
Yes. It contains Abemaciclib, the same active ingredient as Verzenio.
6. Do I need a prescription for Abeclib® 150mg?
Yes. It is a prescription-only medicine.
7. Can pregnant women take Abemaciclib?
No. It may harm the unborn baby and should be avoided during pregnancy.
Medical Disclaimer
Disclaimer:
The information provided is for educational purposes only and should not be considered medical advice. Abemaciclib is a prescription-only medicine and must be used under the supervision of a qualified healthcare professional. Always consult your doctor before starting or stopping any medication.
